Bone Marrow TransplantationPeripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousStem CellsHematopoietic Stem CellsHematopoietic Stem Cell MobilizationBone MarrowGraft vs Host DiseaseTransplantation ConditioningBone Marrow CellsAdult Stem CellsStem Cell TransplantationGranulocyte Colony-Stimulating FactorHematologic NeoplasmsLeukapheresisEmbryonic Stem CellsGraft SurvivalAntigens, CD34Tissue DonorsWhole-Body IrradiationBlood Component RemovalBusulfanCyclophosphamideCombined Modality TherapyCell DifferentiationTransplantation ChimeraMelphalanTreatment OutcomeLeukemiaHistocompatibilityHistocompatibility TestingAnemia, AplasticRecurrenceBone Marrow PurgingMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsHematopoiesisLymphoma, Non-HodgkinCord Blood Stem Cell TransplantationImmunosuppressive AgentsRemission InductionTime FactorsBone and BonesBlood CellsTransplantation, IsogeneicRetrospective StudiesCytomegalovirus InfectionsBone Marrow DiseasesEtoposideLeukemia, Myeloid, AcuteBlood Cell CountLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyeloablative AgonistsKidney TransplantationSurvival AnalysisHematologic DiseasesLymphocyte DepletionSurvival RateLeukocyte TransfusionDisease-Free SurvivalPrecursor Cell Lymphoblastic Leukemia-LymphomaFlow CytometryColony-Forming Units AssayLiver TransplantationOpportunistic InfectionsInfectionAcute DiseaseThiotepaSalvage TherapyTransplantationCytarabineT-LymphocytesAntineoplastic Agents, AlkylatingImmunosuppressionCyclosporineCell SeparationMyelodysplastic SyndromesCells, CulturedHodgkin DiseaseMice, Inbred C57BLTransplantation ImmunologyPluripotent Stem CellsImmunocompromised HostLeukemia, MyeloidHLA AntigensMesenchymal Stem Cell TransplantationLymphomaFollow-Up StudiesLeukocyte CountHepatic Veno-Occlusive DiseaseBlood DonorsPlatelet CountGraft RejectionGraft vs Leukemia EffectCarmustineImmunophenotypingStem Cell NicheStem Cell Factor